Blue Jet Healthcare Stock Screener | Share Price & Fundamental Analysis
BLUEJET
Pharmaceuticals
Share Price NSE
₹355.85
▼
-8.35 (-2.29%)
Share Price BSE
₹355.45
▼
-9.25 (-2.54%)
Track Blue Jet Healthcare share price live with TickJournal's free stock screener.
Analyze Blue Jet Healthcare share price history trends and compare 52-week high low
levels.
Calculate BLUEJET stock fair value using fundamental analysis and view live share price charts.
Determine Blue Jet Healthcare share intrinsic value and compare it with current BLUEJET share price.
Record your Blue Jet Healthcare trades in TickJournal's free trading journal and track your portfolio performance.
Blue Jet Healthcare Market Cap
₹6,230.88 Cr.
EPS (TTM)
₹1396.27
Dividend Yield
0.30%
Debt to Equity
0.24
BLUEJET 52 Week High
₹1010.20
Blue Jet Healthcare 52 Week Low
₹355.85
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹536.00
Total Equity
₹340.00
Blue Jet Healthcare Share Price History - Stock Screener Chart
Screen BLUEJET historical share price movements with interactive charts. Analyze price trends and patterns.
Blue Jet Healthcare Company Profile - Fundamental Screener
Screen Blue Jet Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BLUEJET shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0KBH01020
Blue Jet Healthcare Balance Sheet Screener
Screen BLUEJET balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2021 | 2020 |
|---|---|---|
| Assets | ||
| Total Assets | 536 | 375 |
| Current Assets | 390 | 249 |
| Fixed Assets | 139 | 107 |
| Liabilities | ||
| Total Liabilities | 536 | 375 |
| Current Liabilities | 33 | 39 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 340 | 203 |
| Share Capital | 10 | 1 |
| Reserves & Surplus | 320 | 182 |
Blue Jet Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Blue Jet Healthcare income statement and profit fundamentals.
Analyze BLUEJET quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Blue Jet Healthcare share price evaluation.
| Item | None-None | 2021-March | 2020-March |
|---|---|---|---|
| Revenue | 0 | 508 | 544 |
| Expenses | 0 | 293 | 325 |
| EBITDA | 0 | 215 | 220 |
| Operating Profit % | 0.00% | 41.00% | 40.00% |
| Depreciation | 0 | 20 | 18 |
| Interest | 0 | 5 | 7 |
| Profit Before Tax | 0 | 185 | 194 |
| Tax | 0 | 49 | 49 |
| Net Profit | 0 | 136 | 145 |
| EPS | 0.00 | 1396.27 | 1462.60 |
Blue Jet Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen BLUEJET cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2021-March | 2020-March |
|---|---|---|
| Operating Activities | 129 | 123 |
| Investing Activities | -51 | -45 |
| Financing Activities | -28 | -73 |
| Net Cash Flow | 51 | 5 |
Blue Jet Healthcare Shareholding Pattern Screener
See Blue Jet Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Blue Jet Healthcare promoter holding and ownership changes for BLUEJET on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 86.00% | 86.00% | 79.81% | 79.81% | 86.00% | 86.00% | 86.00% | 86.00% |
| FII Holding | 2.29% | 1.97% | 1.82% | 1.14% | 2.01% | 2.02% | 2.18% | 1.10% |
| DII Holding | 1.33% | 0.94% | 3.63% | 4.65% | 3.03% | 2.14% | 1.74% | 2.02% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 7.28% | 8.03% | 9.78% | 9.91% | 5.36% | 5.79% | 5.90% | 6.30% |
| Other Holding | 3.10% | 3.05% | 4.95% | 4.50% | 3.60% | 4.04% | 4.17% | 4.57% |
| Shareholder Count | 54,581 | 70,772 | 80,117 | 80,187 | 48,625 | 42,882 | 41,933 | 43,003 |
Blue Jet Healthcare Share Dividend Screener - Share Yield Analysis
Check Blue Jet Healthcare dividend history with payout and yield data.
View Blue Jet Healthcare dividend details including ex-dates and amounts for BLUEJET stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.20 | 0.30% |
| 2024-March | ₹1.00 | 0.11% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Blue Jet Healthcare Stock Index Membership
See which indices include Blue Jet Healthcare stock.
Check BLUEJET index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Blue Jet Healthcare Market Events Screener - Corporate Actions
Get Blue Jet Healthcare corporate actions including splits, bonuses, and buybacks.
Check Blue Jet Healthcare stock events that may affect BLUEJET share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.20 /share | -11.15% | ||
| Annual General Meeting | NA | 3.98% | ||
| Dividend | ₹ 1.00 /share | 40.27% | ||
| Annual General Meeting | NA | -13.73% | ||
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 8.58% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 5.67% |
| 2025-07-22 | 2025-07-22 | Quarterly Result Announcement | NA | 5.40% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | 6.36% |
| 2025-01-29 | 2025-01-29 | Quarterly Result Announcement | NA | -1.39% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | 1.40% |
Blue Jet Healthcare Competitors Screener - Peer Comparison
Screen BLUEJET competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 407,743 | 37.20 | 54,729 | 9.71% | 10,980 | 52.49 |
| Divis Laboratories | 164,670 | 66.07 | 9,712 | 18.67% | 2,191 | 48.87 |
| Torrent Pharmaceuticals | 145,261 | 64.43 | 11,539 | 6.99% | 1,911 | 59.36 |
| Cipla | 108,645 | 23.71 | 28,410 | 7.12% | 5,291 | 35.86 |
| Dr Reddys Laboratories | 105,614 | 19.16 | 33,741 | 16.73% | 5,725 | 58.24 |
| Lupin | 101,323 | 21.52 | 22,910 | 13.74% | 3,306 | 56.93 |
| Zydus Life Science | 91,371 | 18.12 | 23,511 | 18.55% | 4,615 | 51.32 |
| Mankind Pharma | 85,905 | 47.17 | 12,744 | 20.90% | 2,007 | 42.02 |
| Aurobindo Pharma | 68,180 | 19.14 | 32,346 | 9.43% | 3,484 | 45.13 |
| Alkem Laboratories | 65,629 | 26.80 | 13,458 | 3.70% | 2,216 | 36.02 |
Blue Jet Healthcare Company Announcements - News Screener
Screen BLUEJET latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-19 | Outcome Of Board Meeting | View |
| 2026-02-19 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-02-12 | Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 | View |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-12-09 | Update On Implementation Of 1.0 Of SAP S/4HANA By Blue Jet Healthcare Limited | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-04 | Unaudited Financial Result For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-04 | Board Meeting Outcome for Unaudited Standalone Financial Result For The Quarter And Half Year Ended Sep 2025 | View |
| 2025-10-29 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-29 | Board Meeting Intimation for Approval Of The Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025 Along With Limited Review Report As Received From The Statutory Auditor Of The Company | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |